HLL to set up a vaccine complex        Illustrative image – not actual.

HLL Biotech (HBL), a subsidiary of HLL Lifecare (HLL), will soon set up an integrated vaccine complex at Chengalpettu of Kancheepuram district of Tamil Nadu.

 

The complex will be developed at a cost of Rs 594 crore and will be spread across 100 acre.

 

The Tamil Nadu government has chosen HLL Biotech as one of the 16 companies to set up projects for overall industrial development of the state.

 

An MoU was signed between the company and the Tamil Nadu government for the project. HLL Biotech, the subsidiary company of HLL, has been floated by the Tamil Nadu government to implement this project.

 

Construction work on the project is still in progress and the products from the facility will be ready for trial in another 18 months.

 

In Phase-I, the company will manufacture pentavalent combination (DPT plus Hepatitis- B plus Hib), BCG, Measles, Hepatitis B, Human Rabies, Hib and Japanese Encephalitis (JE) vaccines. The annual capacity of the vaccines will be 585 Mn doses.

 

Also, the company is seeking to develop a strong R&D base for development of futuristic vaccines, apart from manufacturing and supplying vaccines required for the Universal Immunisation Programme (UIP) of India.

 

Related Link:
Project profile

← All latest storiesBack to top →